[HTML][HTML] Actinium-225 targeted alpha particle therapy for prostate cancer
Targeted alpha particle therapy (TAT) has emerged as a promising strategy for the treatment
of prostate cancer (PCa). Actinium-225 (225 Ac), a potent alpha-emitting radionuclide, may …
of prostate cancer (PCa). Actinium-225 (225 Ac), a potent alpha-emitting radionuclide, may …
Advances in targeted alpha therapy of cancer
M Sathekge, A Morgenstern - European Journal of Nuclear Medicine and …, 2024 - Springer
There is remarkable interest worldwide on the use of targeted alpha therapy on several
cancers such as brain tumors, bladder cancer, neuroendocrine tumors, leukemia, and …
cancers such as brain tumors, bladder cancer, neuroendocrine tumors, leukemia, and …
[HTML][HTML] Actinium-225 in Targeted Alpha Therapy
AKMR Rahman, MH Babu, MK Ovi… - Journal of Medical …, 2024 - journals.lww.com
Abstract The utilization of actinium-225 (225 Ac) radionuclides in targeted alpha therapy for
cancer was initially outlined in 1993. Over the past two decades, substantial research has …
cancer was initially outlined in 1993. Over the past two decades, substantial research has …
[PDF][PDF] Production of the state of the art therapeutic radiopharmaceuticals in Iran, from beta-to alpha-emitting targeted radionuclide therapy: Clinical advances and …
Iran has had many achievements in recent years in producing different diagnostic and
therapeutic radiopharmaceuticals [1]. Presence of over 210 nuclear medicine centers and …
therapeutic radiopharmaceuticals [1]. Presence of over 210 nuclear medicine centers and …
Effects of alpha particles on cells
D Valiukevičiūtė - 2024 - epubl.ktu.edu
Abstract [eng] Targeted alpha therapy (TAT) shows promising results for precise and
selective radiotherapy with effective cancer treatment and minimal toxicity. Alpha particle …
selective radiotherapy with effective cancer treatment and minimal toxicity. Alpha particle …